Literature DB >> 24927248

Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging.

Ryo Tamura1, Katsunori Kashima, Mina Asatani, Koji Nishino, Nobumichi Nishikawa, Masayuki Sekine, Takehiro Serikawa, Takayuki Enomoto.   

Abstract

OBJECTIVE: The differential diagnosis between uterine sarcoma and benign leiomyoma is difficult when made only by magnetic resonance imaging (MRI); it usually requires an additional preoperative diagnostic procedure. We report our results using ultrasound-guided needle biopsy for these types of uterine tumors.
METHODS: Ultrasound-guided needle biopsy was performed on 63 patients with uterine smooth muscle tumors suspected of malignancy by MRI. We compared the results of presurgical biopsy against the postsurgical pathology of the tumor.
RESULTS: Among 63 patients with a high signal intensity of the uterine tumor on T2-weighted MRI (1 case was undetermined), 12 cases (19.3%) were diagnosed by the needle biopsy as malignant, and 51 cases (80.6%) were benign. Among the 12 diagnosed as malignant tumors, 11 had surgery performed, and one was treated with chemotherapy. Among the 51 patients diagnosed with a benign tumor, 27 had surgery performed, and 24 were put on a wait-and-see clinical follow-up schedule. One of the 27 surgical patients with a benign tumor had a postsurgical diagnosis of a low-grade endometrial stromal sarcoma. In the 38 cases where surgery was performed, we found the sensitivity, specificity, and the positive and negative predictive values of the needle biopsy were 91.7%, 100%, 100%, and 96.2%, respectively.
CONCLUSIONS: Ultrasound-guided needle biopsy may be a reliable preoperative diagnostic procedure for uterine tumors with suspected malignancy.

Entities:  

Mesh:

Year:  2014        PMID: 24927248     DOI: 10.1097/IGC.0000000000000189

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

Review 1.  High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches.

Authors:  Charles-André Philip; Patricia Pautier; Florence Duffaud; Isabelle Ray-Coquard
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

2.  Intravenous low-grade endometrial stromal sarcoma with intracardiac extension: A CASE OF inaccurate tumor location on contrast-enhanced computed tomography.

Authors:  Yuya Nogami; Wataru Yamagami; Junko Maki; Kouji Banno; Nobuyuki Susumu; Koichi Tomita; Kentaro Matsubara; Hideaki Obara; Yuko Kitagawa; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2015-12-02

3.  Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGG.

Authors:  M W Beckmann; I Juhasz-Böss; D Denschlag; P Gaß; T Dimpfl; P Harter; P Mallmann; S P Renner; S Rimbach; I Runnebaum; M Untch; S Y Brucker; D Wallwiener
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-02       Impact factor: 2.915

Review 4.  Advances in the Preoperative Identification of Uterine Sarcoma.

Authors:  Junxiu Liu; Zijie Wang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

Review 5.  Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.

Authors:  Klaudia Żak; Bartłomiej Zaremba; Alicja Rajtak; Jan Kotarski; Frédéric Amant; Marcin Bobiński
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

Review 6.  Role of surgery in gynaecological sarcomas.

Authors:  Valentina Ghirardi; Nicolò Bizzarri; Francesco Guida; Carmine Vascone; Barbara Costantini; Giovanni Scambia; Anna Fagotti
Journal:  Oncotarget       Date:  2019-04-02

7.  Ultrasound-guided Needle Biopsy for Preoperative Assessment of Uterine Fibroids: Our Experience and a Review of the Literature.

Authors:  Carlo Alboni; Ludovica Camacho Mattos; Stefania Malmusi; Maria Cristina Galassi; Fabio Facchinetti; Mohamed Mabrouk
Journal:  Gynecol Minim Invasive Ther       Date:  2022-02-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.